Last update Feb. 28, 2023
Very Low Risk
Monobactamic antibiotic which is similar to penicillins. Indicated for the treatment of infections caused by susceptible Gram-negative aerobic organisms. Intravenous administration.
It is excreted into breast milk in insignificant amount. (Ito 1990, Fleiss 1985)
Its almost zero oral bioavailability makes it difficult for it to pass to the infant plasma from ingested breast milk, except in premature infants and in the immediate neonatal period in which there may be greater intestinal permeability.
It is commonly prescribed to children and newborns.
Several medical societies and expert authors consider the use of this medication to be safe or very probably safe during breastfeeding. (Hale, Middleton 2020, Briggs 2015, Schaefer 2015)
American Academy of Pediatrics: medication usually compatible with breastfeeding.(AAP 2001)
We do not have alternatives for Aztreonam since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM